Drugs.com - FDA MedWatch Alerts

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Audience: Healthcare Professional, Pharmacy, Consumer MALVERN, PA, December 20, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots...

Feb 9, 2025 - 21:44
 0
Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors
Audience: Healthcare Professional, Pharmacy, Consumer MALVERN, PA, December 20, 2024 – Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots...
Read More

Tags:

Previous Article

Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0...

Next Article

Alcon Laboratories Issues Voluntary Nationwide Recall of One Lot of Systane Lubr...

Related Posts

FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs from Fullerton Wellness

FDA Warns Patients and Health Care Professionals Not to...

Feb 9, 2025  0

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL (10mg/mL) Bags

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nation...

Feb 9, 2025  0

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

Feb 9, 2025  0